The Study of EIT-guided Ventilation Strategy on ARDS Patients
1 other identifier
interventional
100
1 country
1
Brief Summary
This study is a clinical randomized controlled study.The objective of this study is to compare the prognosis of patients with ARDS between eit-v / q-oriented individualized ventilation strategy and traditional lung protection ventilation strategy, and to establish the demonstration application of eit-v / q-oriented ventilation strategy in ARDS
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2021
CompletedFirst Submitted
Initial submission to the registry
January 28, 2021
CompletedFirst Posted
Study publicly available on registry
February 2, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2023
CompletedFebruary 2, 2021
January 1, 2021
2.4 years
January 28, 2021
January 28, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
ventilation free days
1 Day
Secondary Outcomes (1)
28-day mortality
28 days
Study Arms (2)
EIT-guided group
EXPERIMENTALTreatment based on EIT
Control group
PLACEBO COMPARATORTreatment based on ARDS-net Peep setting
Interventions
Eligibility Criteria
You may qualify if:
- According to ARDS Berlin standard, ARDS, PaO2 / FiO2 \< 200mmhg, peep \> 5cmh2o;
- According to clinical judgment, lung recruitment therapy is needed due to hypoxemia;
- The subjects or their families signed informed consent.
- Admission to ICU was less than 72 hours;
- The estimated duration of mechanical ventilation was more than or equal to 48 hours;
- Age ≥ 18 years old and ≤ 80 years old;
You may not qualify if:
- The patients with heart implants could not be monitored by EIT;
- Patients or their families refused to participate in the study;
- Hypernatremia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 28, 2021
First Posted
February 2, 2021
Study Start
January 1, 2021
Primary Completion
June 1, 2023
Study Completion
June 1, 2023
Last Updated
February 2, 2021
Record last verified: 2021-01
Data Sharing
- IPD Sharing
- Will not share